105 related articles for article (PubMed ID: 31669575)
1. Activation of AMPK promotes thyroid cancer cell migration through its interaction with PKM2 and β-catenin.
Chen J; Zhou Q; Feng J; Zheng W; Du J; Meng X; Wang Y; Wang J
Life Sci; 2019 Dec; 239():116877. PubMed ID: 31669575
[TBL] [Abstract][Full Text] [Related]
2. Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.
Liu M; Zhang Z; Wang H; Chen X; Jin C
Int J Biol Sci; 2019; 15(3):617-627. PubMed ID: 30745848
[TBL] [Abstract][Full Text] [Related]
3. Pyruvate kinase M knockdown-induced signaling via AMP-activated protein kinase promotes mitochondrial biogenesis, autophagy, and cancer cell survival.
Prakasam G; Singh RK; Iqbal MA; Saini SK; Tiku AB; Bamezai RNK
J Biol Chem; 2017 Sep; 292(37):15561-15576. PubMed ID: 28778925
[TBL] [Abstract][Full Text] [Related]
4. Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling.
Xie X; Huang X; Tang H; Ye F; Yang L; Guo X; Tian Z; Xie X; Peng C; Xie X
Curr Cancer Drug Targets; 2018; 18(6):592-599. PubMed ID: 29110616
[TBL] [Abstract][Full Text] [Related]
5. PAK2-c-Myc-PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect.
Gupta A; Ajith A; Singh S; Panday RK; Samaiya A; Shukla S
Cell Death Dis; 2018 Aug; 9(8):825. PubMed ID: 30068946
[TBL] [Abstract][Full Text] [Related]
6. IGF-1-mediated PKM2/β-catenin/miR-152 regulatory circuit in breast cancer.
Wen YY; Liu WT; Sun HR; Ge X; Shi ZM; Wang M; Li W; Zhang JY; Liu LZ; Jiang BH
Sci Rep; 2017 Nov; 7(1):15897. PubMed ID: 29162853
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA MEG3 suppresses liver cancer cells growth through inhibiting β-catenin by activating PKM2 and inactivating PTEN.
Zheng Q; Lin Z; Xu J; Lu Y; Meng Q; Wang C; Yang Y; Xin X; Li X; Pu H; Gui X; Li T; Xiong W; Lu D
Cell Death Dis; 2018 Feb; 9(3):253. PubMed ID: 29449541
[TBL] [Abstract][Full Text] [Related]
8. PKM2 depletion induces the compensation of glutaminolysis through β-catenin/c-Myc pathway in tumor cells.
Wu H; Li Z; Yang P; Zhang L; Fan Y; Li Z
Cell Signal; 2014 Nov; 26(11):2397-405. PubMed ID: 25041845
[TBL] [Abstract][Full Text] [Related]
9. ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
Yang W; Zheng Y; Xia Y; Ji H; Chen X; Guo F; Lyssiotis CA; Aldape K; Cantley LC; Lu Z
Nat Cell Biol; 2012 Dec; 14(12):1295-304. PubMed ID: 23178880
[TBL] [Abstract][Full Text] [Related]
10. 5'-AMP-Activated Protein Kinase Regulates Papillary (TPC-1 and BCPAP) Thyroid Cancer Cell Survival, Migration, Invasion, and Epithelial-to-Mesenchymal Transition.
Cazarin JM; Coelho RG; Hecht F; Andrade BM; Carvalho DP
Thyroid; 2016 Jul; 26(7):933-42. PubMed ID: 27121619
[TBL] [Abstract][Full Text] [Related]
11. Nuclear translocation of PKM2/AMPK complex sustains cancer stem cell populations under glucose restriction stress.
Yang YC; Chien MH; Liu HY; Chang YC; Chen CK; Lee WJ; Kuo TC; Hsiao M; Hua KT; Cheng TY
Cancer Lett; 2018 May; 421():28-40. PubMed ID: 29408265
[TBL] [Abstract][Full Text] [Related]
12. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
13. Pyruvate kinase, muscle isoform 2 promotes proliferation and insulin secretion of pancreatic β-cells via activating Wnt/CTNNB1 signaling.
Wang S; Yang Z; Gao Y; Li Q; Su Y; Wang Y; Zhang Y; Man H; Liu H
Int J Clin Exp Pathol; 2015; 8(11):14441-8. PubMed ID: 26823761
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Kinase-Induced PKM2 Tyrosine 105 Phosphorylation Converts Nononcogenic PKM2 to a Tumor Promoter and Induces Cancer Stem-like Cells.
Zhou Z; Li M; Zhang L; Zhao H; Şahin Ö; Chen J; Zhao JJ; Songyang Z; Yu D
Cancer Res; 2018 May; 78(9):2248-2261. PubMed ID: 29440169
[TBL] [Abstract][Full Text] [Related]
15. PKM2 inhibitor shikonin suppresses TPA-induced mitochondrial malfunction and proliferation of skin epidermal JB6 cells.
Li W; Liu J; Zhao Y
Mol Carcinog; 2014 May; 53(5):403-12. PubMed ID: 23255458
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway.
Xu Q; Wu N; Li X; Guo C; Li C; Jiang B; Wang H; Shi D
Cell Death Dis; 2019 Nov; 10(12):874. PubMed ID: 31745071
[TBL] [Abstract][Full Text] [Related]
17. Phosphorylation of pyruvate kinase M2 and lactate dehydrogenase A by fibroblast growth factor receptor 1 in benign and malignant thyroid tissue.
Kachel P; Trojanowicz B; Sekulla C; Prenzel H; Dralle H; Hoang-Vu C
BMC Cancer; 2015 Mar; 15():140. PubMed ID: 25880801
[TBL] [Abstract][Full Text] [Related]
18. Nuclear translocation of PKM2 modulates astrocyte proliferation via p27 and -catenin pathway after spinal cord injury.
Zhang J; Feng G; Bao G; Xu G; Sun Y; Li W; Wang L; Chen J; Jin H; Cui Z
Cell Cycle; 2015; 14(16):2609-18. PubMed ID: 26151495
[TBL] [Abstract][Full Text] [Related]
19. AMPK interacts with β-catenin in the regulation of hepatocellular carcinoma cell proliferation and survival with selenium treatment.
Park SY; Lee YK; Kim HJ; Park OJ; Kim YM
Oncol Rep; 2016 Mar; 35(3):1566-72. PubMed ID: 26707164
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of pyruvate kinase M2 isoform inhibits cell motility in hepatocellular carcinoma cells.
Chen YL; Song JJ; Chen XC; Xu W; Zhi Q; Liu YP; Xu HZ; Pan JS; Ren JL; Guleng B
World J Gastroenterol; 2015 Aug; 21(30):9093-102. PubMed ID: 26290635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
